How much tirzepatide to take — and why that question also shapes what you pay

The biggest myth: you pick a dose and stay on it

A lot of people arrive at consultation expecting to choose a strength the way they'd choose a supplement. That's not how tirzepatide works in practice. Treatment starts at 2.5 mg, which exists specifically to let the body adjust. It's a settling-in period, not the dose doing the heavy lifting. From there, a prescriber typically steps the dose up every four weeks, moving through 5 mg, 7.5 mg, 10 mg, 12.5 mg and, if needed, 15 mg. Each step only happens when it's clinically appropriate.

Why does this matter for cost? Because the pen you receive at 5 mg and the pen you receive at 15 mg are priced differently in the UK private market. Eli Lilly adjusted UK list prices from September 2025, with the highest dose rising to around £330 per four-week pen. Private providers price from roughly £149 to £375 per month depending on dose and clinic. Those figures are reported context, not a guarantee of what any given provider charges.

The clinical point is the one worth sitting with: taking more tirzepatide than your prescriber has directed doesn't produce faster results and carries real risks. Dose is titrated to balance effectiveness with tolerability, not pushed to the ceiling as quickly as possible. The NHS tirzepatide medicines page covers what to expect during dose changes in plain terms.

The NICE appraisal of tirzepatide (TA1026) notes that if less than 5% weight loss occurs after six months at the highest tolerated dose, continuing treatment should be reviewed. That framing (highest tolerated) is the language of clinical judgment, not personal preference.

What a quoted price often leaves out

Headline prices in this market have a habit of looking clean until you read the small print. Many published figures cover the pen alone. They do not always include the initial consultation, the ongoing prescription fee, delivery, or any clinical support between doses. Some providers charge separately for dose-review calls or require a separate subscription for aftercare. None of that is hidden in a malicious sense, but it means comparing two price tags without knowing what each one contains is genuinely difficult.

The question of what drives tirzepatide pricing in the UK is a reasonable one to ask. A short answer: you are paying for a regulated medicine sourced through the licensed supply chain, for a clinician's time to assess you, and for the infrastructure that keeps that assessment safe. A longer answer lives on our pricing page.

There's also a practical detail worth knowing. Mounjaro KwikPens are refrigerated, stored at 2–8°C; many patients keep them in the fridge door. When your prescription changes dose, if you want a clear guide on how much Mounjaro to take at each stage of treatment, that page walks through the titration schedule in plain terms. At nume, every repeat is reviewed again before it goes out, so there's no auto-renewal sending you stock you may no longer need.

Our position, and why we're not competing on price

We'll say this once, clearly. We're not the cheapest option in the UK private market, and that's deliberate. Cheapest isn't a race we entered, because the category of thing you're buying (a prescription medicine requiring ongoing clinical oversight) is not one where the lowest number wins.

The single price at nume covers the consultation, the prescription, the medicine itself, tracked next-working-day DPD delivery, and seven-day aftercare from our clinical team. Nothing is itemised out or added on later. You can see current treatment pricing on our weight-loss treatments page, and for a fuller breakdown of how Mounjaro pricing works across the market, that page goes into the detail.

Our pharmacy is GPhC-registered (premises registration 9012878, verifiable on the GPhC register) and every consultation is read by a named clinician. You can read more about the clinical team if you want to know who is reviewing your case.

Why 'cheapest' is the wrong question for a prescription medicine

The MHRA has warned repeatedly about fake weight-loss pens circulating online, including counterfeit tirzepatide. Some contain insulin rather than tirzepatide. Large volumes of illegally traded product have been seized, with the first illicit UK manufacturing site for counterfeit tirzepatide raided in 2025. Suspiciously low prices, sellers on social media, and offers of supply without a clinical assessment are the pattern to watch for. If you come across a seller operating that way, the MHRA Yellow Card scheme accepts reports of suspect sellers alongside side-effect reports.

The right questions for a prescription medicine are about legitimacy: is this dispensed by a pharmacy you can verify, has a clinician actually assessed whether it's appropriate for you, and is the supply chain the licensed one? A small saving against those concerns isn't a saving at all. For a fuller picture of how much tirzepatide costs in the UK and what shapes that figure, our dedicated cost page works through the detail. If you also want practical guidance on how much tirzepatide to inject and what the correct volumes look like, that page covers the detail clearly. And if you'd like to understand more about tirzepatide generally before deciding, the Mounjaro overview is a good starting point.

When you're ready to have your situation looked at properly, our prescribers are here. Start your free consultation and a clinician will review your case the same day.